Prevalences of diabetic retinopathy and nephropathy are lower in Korean type 2 diabetic patients with non-alcoholic fatty liver disease

被引:61
作者
Kim, Bo-Yeon [1 ]
Jung, Chan-Hee [1 ]
Mok, Ji-Oh [1 ]
Kang, Sung Koo [1 ]
Kim, Chul-Hee [1 ]
机构
[1] Soonchunhyang Univ, Bucheon Hosp, Div Endocrinol & Metab, Dept Internal Med, Puchon, South Korea
来源
JOURNAL OF DIABETES INVESTIGATION | 2014年 / 5卷 / 02期
关键词
Diabetes mellitus type 2; Diabetic angiopathies; Non-alcoholic fatty liver disease; CORONARY-HEART-DISEASE; C-PEPTIDE; CARDIOVASCULAR-DISEASE; LIPID-PEROXIDATION; RISK-FACTORS; EVENTS;
D O I
10.1111/jdi.12139
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/IntroductionThe associations between non-alcoholic fatty liver disease (NAFLD) and chronic vascular complications of type 2 diabetes remain uncertain. We assessed the relationships between NAFLD and chronic vascular complications in patients with type 2 diabetes. Materials and MethodsPatients with type 2 diabetes (n=929) attending a diabetes clinic of a university hospital were studied retrospectively. Patients who had any clinical evidence of cirrhosis or other causes of chronic liver disease were excluded. Prevalences of chronic microvascular and macrovascular complications were assessed. NAFLD was ascertained by ultrasonography. ResultsThe prevalence of NAFLD in patients with type 2 diabetes was 63.3%. The prevalences of diabetic retinopathy and nephropathy were significantly lower in patients with NAFLD than those without NAFLD (33.0 vs 70.2%, P<0.001; 29.3 vs 37.1%, P=0.007, respectively), whereas no difference was found in the prevalence of diabetic neuropathy. The prevalence of diabetic macrovascular complications was lower in type 2 diabetic patients with NAFLD than those without NAFLD (9.2 vs 14.7%, P=0.008). After adjustment for confounding factors, such as age, sex, glycated hemoglobin, fasting serum C-peptide, diabetic duration, body mass index and hypertension, NAFLD remained significantly associated with a lower odds ratio (OR) of diabetic retinopathy (OR 0.440, 95% confidence interval 0.255-0.757, P=0.003) and nephropathy, (OR 0.541, 95% confidence interval 0.358-0.817, P=0.003). In contrast, NAFLD was not significantly associated with macrovascular complications after adjustment for confounding factors. ConclusionsThese results suggest that NAFLD is inversely associated with prevalences of diabetic retinopathy and nephropathy in Korean patients with type 2 diabetes.
引用
收藏
页码:170 / 175
页数:6
相关论文
共 50 条
  • [41] Non-alcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive Type 2 diabetic individuals
    A. Mantovani
    G. Zoppini
    G. Targher
    G. Golia
    E. Bonora
    Journal of Endocrinological Investigation, 2012, 35 : 215 - 218
  • [42] Visceral Adipose Tissue and Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes
    Nobarani, Sohrab
    Alaei-Shahmiri, Fariba
    Aghili, Rokhsareh
    Malek, Mojtaba
    Poustchi, Hossein
    Lahouti, Maryam
    Khamseh, Mohammad E.
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (04) : 1389 - 1398
  • [43] Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus
    Leite, Nathalie C.
    Salles, Gil F.
    Araujo, Antonio L. E.
    Villela-Nogueira, Cristiane A.
    Cardoso, Claudia R. L.
    LIVER INTERNATIONAL, 2009, 29 (01) : 113 - 119
  • [44] Association of non-alcoholic fatty liver disease with diabetic microvascular and macrovascular complications in South Indian diabetic subjects
    Viswanathan, Vijay
    Kadiri, Mahesh
    Medimpudi, Srikanth
    Kumpatla, Satyavani
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2010, 30 (04) : 208 - 212
  • [45] Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis: An Epidemic that will Boost the Incidence of Cardiovascular Morbidity and Mortality
    Athyros, Vasilios G.
    Doumas, Michael
    CURRENT VASCULAR PHARMACOLOGY, 2018, 16 (03) : 206 - 208
  • [46] Non-alcoholic fatty liver disease is not associated with a lower health perception
    Mlynarsky, Liat
    Schlesinger, Dalit
    Lotan, Roni
    Webb, Muriel
    Halpern, Zamir
    Santo, Erwin
    Shibolet, Oren
    Zelber-Sagi, Shira
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (17) : 4362 - 4372
  • [47] Non-alcoholic fatty liver disease and cardiovascular risk
    Brea, Angel
    Puzo, Jose
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (04) : 1109 - 1117
  • [48] Non-alcoholic Fatty Liver Disease: A Review of Anti-diabetic Pharmacologic Therapies
    Snyder, Heather S.
    Sakaan, Sami A.
    March, Katherine L.
    Siddique, Osama
    Cholankeril, Rosann
    Cummings, Carolyn D.
    Gadiparthi, Chiran
    Satapathy, Sanjaya K.
    Ahmed, Aijaz
    Cholankeril, George
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2018, 6 (02) : 168 - 174
  • [49] A concise review of non-alcoholic fatty liver disease
    Than, Nwe Ni
    Newsome, Philip N.
    ATHEROSCLEROSIS, 2015, 239 (01) : 192 - 202
  • [50] Are statins 'IDEAL' for non-alcoholic fatty liver disease?
    Athyros, Vasilios G.
    Katsiki, Niki
    Karagiannis, Asterios
    Mikhailidis, Dimitri P.
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (02) : 229 - 231